603309 维力医疗
已收盘 12-16 15:00:00
资讯
新帖
简况
维力医疗(603309)披露公司2025年前三季度利润分配预案,12月11日股价下跌0.67%
证券之星 · 12-11
维力医疗(603309)披露公司2025年前三季度利润分配预案,12月11日股价下跌0.67%
维力医疗(603309)披露2025年前三季度拟每10股派2元分红预案,11月28日股价上涨0.22%
证券之星 · 11-28
维力医疗(603309)披露2025年前三季度拟每10股派2元分红预案,11月28日股价上涨0.22%
维力医疗最新公告:前三季度拟向全体股东每10股派发现金红利2元
证券之星 · 11-25
维力医疗最新公告:前三季度拟向全体股东每10股派发现金红利2元
维力医疗最新公告:公司产品入选《广州市创新药械产品目录》
证券之星 · 10-29
维力医疗最新公告:公司产品入选《广州市创新药械产品目录》
每周股票复盘:维力医疗(603309)Q3净利增16.31%,股东户数增9.29%
证券之星 · 10-26
每周股票复盘:维力医疗(603309)Q3净利增16.31%,股东户数增9.29%
【机构调研记录】金元顺安基金调研维力医疗
证券之星 · 10-22
【机构调研记录】金元顺安基金调研维力医疗
【机构调研记录】红塔红土调研维力医疗
证券之星 · 10-22
【机构调研记录】红塔红土调研维力医疗
【机构调研记录】格林基金调研维力医疗
证券之星 · 10-22
【机构调研记录】格林基金调研维力医疗
【私募调研记录】翼虎投资调研华邦健康、维力医疗
证券之星 · 10-22
【私募调研记录】翼虎投资调研华邦健康、维力医疗
【私募调研记录】名禹资产调研维力医疗
证券之星 · 10-22
【私募调研记录】名禹资产调研维力医疗
维力医疗(603309)2025年三季报简析:营收净利润同比双双增长,公司应收账款体量较大
证券之星 · 10-22
维力医疗(603309)2025年三季报简析:营收净利润同比双双增长,公司应收账款体量较大
股市必读:维力医疗(603309)10月21日披露最新机构调研信息
证券之星 · 10-22
股市必读:维力医疗(603309)10月21日披露最新机构调研信息
维力医疗(603309)9月30日股东户数1.89万户,较上期增加9.29%
证券之星 · 10-20
维力医疗(603309)9月30日股东户数1.89万户,较上期增加9.29%
维力医疗(603309.SH)发布前三季度业绩,归母净利润1.92亿元,同比增长14.94%
智通财经 · 10-20
维力医疗(603309.SH)发布前三季度业绩,归母净利润1.92亿元,同比增长14.94%
每周股票复盘:维力医疗(603309)股东质押1460万股并回购99.66万股
证券之星 · 10-19
每周股票复盘:维力医疗(603309)股东质押1460万股并回购99.66万股
维力医疗(603309)披露股东部分股份质押及解除质押公告,10月13日股价下跌1.62%
证券之星 · 10-13
维力医疗(603309)披露股东部分股份质押及解除质押公告,10月13日股价下跌1.62%
维力医疗(603309.SH)子公司海南维力收到一项医疗器械注册证
智通财经 · 09-25
维力医疗(603309.SH)子公司海南维力收到一项医疗器械注册证
维力医疗(603309.SH)子公司产品获得二类医疗器械注册证
智通财经 · 09-12
维力医疗(603309.SH)子公司产品获得二类医疗器械注册证
维力医疗(603309.SH)子公司取得一项医疗器械注册证
智通财经 · 09-04
维力医疗(603309.SH)子公司取得一项医疗器械注册证
每周股票复盘:维力医疗(603309)参与设立15,000万元产业投资基金完成备案
证券之星 · 08-17
每周股票复盘:维力医疗(603309)参与设立15,000万元产业投资基金完成备案
公司概况
公司名称:
广州维力医疗器械股份有限公司
所属行业:
专用设备制造业
上市日期:
2015-03-02
主营业务:
广州维力医疗器械股份有限公司的主营业务是麻醉、泌尿、呼吸、血液透析等领域医用导管的研发、生产和销售。公司的主要产品是气管插管、喉罩、支气管插管、可视支气管插管、气管切开插管、麻醉面罩、人工鼻、麻醉呼吸管路、电子镇痛泵、导尿管、导尿包、抗菌导尿管、测温导尿管、引流袋、男用导尿套、精密尿袋清石鞘、微创扩张引流套件、导丝、球囊扩张导管、输尿管扩张器、输尿管导引鞘、取石篮、输尿管支架、输尿管导管。
发行价格:
15.40
{"stockData":{"symbol":"603309","market":"SH","secType":"STK","nameCN":"维力医疗","latestPrice":13.18,"timestamp":1765868401000,"preClose":13.3,"halted":0,"volume":2323199,"delay":0,"changeRate":-0.009,"floatShares":292000000,"shares":292000000,"eps":0.8371,"marketStatus":"已收盘","change":-0.12,"latestTime":"12-16 15:00:00","open":13.32,"high":13.37,"low":13.17,"amount":30761900,"amplitude":0.015,"askPrice":13.18,"askSize":16,"bidPrice":13.17,"bidSize":108,"shortable":0,"etf":0,"ttmEps":0.8371,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765935000000},"marketStatusCode":5,"adr":0,"adjPreClose":13.3,"symbolType":"stock","openAndCloseTimeList":[[1765848600000,1765855800000],[1765861200000,1765868400000]],"highLimit":14.63,"lowLimit":11.97,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":291871418,"isCdr":false,"pbRate":1.99,"roa":"--","peRate":15.744833,"roe":"10.0%","epsLYR":0.75,"committee":0.349096,"marketValue":3847000000,"turnoverRate":0.008,"status":1,"floatMarketCap":3847000000},"requestUrl":"/m/hq/s/603309/wiki","defaultTab":"wiki","newsList":[{"id":"2590514656","title":"维力医疗(603309)披露公司2025年前三季度利润分配预案,12月11日股价下跌0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590514656","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590514656?lang=zh_cn&edition=full","pubTime":"2025-12-11 22:26","pubTimestamp":1765463208,"startTime":"0","endTime":"0","summary":"截至2025年12月11日收盘,维力医疗报收于13.4元,较前一交易日下跌0.67%,最新总市值为39.11亿元。该股当日开盘13.51元,最高13.53元,最低13.36元,成交额达3117.14万元,换手率为0.8%。根据近日发布的公告,广州维力医疗器械股份有限公司于2025年12月11日召开2025年第二次临时股东会,会议审议通过了《公司2025年前三季度利润分配预案》。出席会议的股东共170人,代表有表决权股份总数的52.0740%。该议案已获得出席会议股东所持有效表决权的过半数通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100042034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603309","BK0251"],"gpt_icon":0},{"id":"2586733349","title":"维力医疗(603309)披露2025年前三季度拟每10股派2元分红预案,11月28日股价上涨0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586733349","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586733349?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:29","pubTimestamp":1764340180,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘,维力医疗报收于13.67元,较前一交易日上涨0.22%,最新总市值为39.9亿元。该股当日开盘13.68元,最高13.68元,最低13.48元,成交额达3228.14万元,换手率为0.81%。本次利润分配不送红股,不以公积金转增股本,剩余未分配利润结转。该预案尚需提交公司股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800040584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603309","BK0251"],"gpt_icon":0},{"id":"2586267144","title":"维力医疗最新公告:前三季度拟向全体股东每10股派发现金红利2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586267144","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586267144?lang=zh_cn&edition=full","pubTime":"2025-11-25 17:53","pubTimestamp":1764064389,"startTime":"0","endTime":"0","summary":"维力医疗(603309.SH)公告称,截至2025年9月30日,公司母公司报表中期末未分配利润为7.04亿元(未经审计)。经董事会决议,公司2025年前三季度拟以实施权益分派股权登记日登记的总股本为基数分配利润。公司拟向全体股东每10股派发现金红利2元(含税)。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500027392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603309"],"gpt_icon":0},{"id":"2579992203","title":"维力医疗最新公告:公司产品入选《广州市创新药械产品目录》","url":"https://stock-news.laohu8.com/highlight/detail?id=2579992203","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579992203?lang=zh_cn&edition=full","pubTime":"2025-10-29 16:47","pubTimestamp":1761727672,"startTime":"0","endTime":"0","summary":"维力医疗(603309.SH)公告称,公司产品一次性使用无菌导尿管和超声引导神经阻滞麻醉穿刺针入选广州市第二批创新药械产品目录。入选产品是对公司产品技术先进性和创新性的认可,有助于提高公司品牌知名度及市场竞争力,对公司创新产品的销售具有积极影响。但短期内对公司经营业绩影响较小,敬请投资者注意投资风险。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900033934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","399265","603309"],"gpt_icon":0},{"id":"2578507066","title":"每周股票复盘:维力医疗(603309)Q3净利增16.31%,股东户数增9.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578507066","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578507066?lang=zh_cn&edition=full","pubTime":"2025-10-26 04:09","pubTimestamp":1761422955,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,维力医疗报收于14.45元,较上周的13.21元上涨9.39%。来自业绩披露要点:2025年第三季度归母净利润同比增长16.31%,经营现金流净额同比增长33.54%。股本股东变化截至2025年9月30日,公司股东户数为1.89万户,较6月30日增加1605户,增幅9.29%。公司公告汇总维力医疗发布2025年第三季度报告,报告期内营收4.46亿元,同比增长16.09%;前三季度累计营收11.91亿元,同比增长12.33%。归母净利润单季7056.6万元,同比增长16.31%;前三季度累计1.92亿元,同比增长14.94%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603309","BK0251"],"gpt_icon":0},{"id":"2577458389","title":"【机构调研记录】金元顺安基金调研维力医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2577458389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577458389?lang=zh_cn&edition=full","pubTime":"2025-10-22 08:01","pubTimestamp":1761091309,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月21日披露的机构调研信息,金元顺安基金近期对1家上市公司进行了调研,相关名单如下:1)维力医疗 调研纪要:印尼工厂正处建设及认证阶段,预计2026年Q1末逐步出货,一期主供美国客户,生产导尿管和吸引连接管,后续或扩产喉罩、气管插管等麻醉类产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200006037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603309"],"gpt_icon":0},{"id":"2577891093","title":"【机构调研记录】红塔红土调研维力医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2577891093","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577891093?lang=zh_cn&edition=full","pubTime":"2025-10-22 08:01","pubTimestamp":1761091305,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月21日披露的机构调研信息,红塔红土近期对1家上市公司进行了调研,相关名单如下:1)维力医疗 调研纪要:印尼工厂正处建设及认证阶段,预计2026年Q1末逐步出货,一期主供美国客户,生产导尿管和吸引连接管,后续或扩产喉罩、气管插管等麻醉类产品。旗下最近一年表现最佳的公募基金产品为红塔红土信息产业精选股票发起式A,最新单位净值为2.03,近一年增长61.98%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200006035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603309","BK0251"],"gpt_icon":0},{"id":"2577389455","title":"【机构调研记录】格林基金调研维力医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2577389455","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577389455?lang=zh_cn&edition=full","pubTime":"2025-10-22 08:01","pubTimestamp":1761091299,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月21日披露的机构调研信息,格林基金近期对1家上市公司进行了调研,相关名单如下:1)维力医疗 调研纪要:印尼工厂正处建设及认证阶段,预计2026年Q1末逐步出货,一期主供美国客户,生产导尿管和吸引连接管,后续或扩产喉罩、气管插管等麻醉类产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200006027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603309","BK0251"],"gpt_icon":0},{"id":"2577389451","title":"【私募调研记录】翼虎投资调研华邦健康、维力医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2577389451","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577389451?lang=zh_cn&edition=full","pubTime":"2025-10-22 08:01","pubTimestamp":1761091270,"startTime":"0","endTime":"0","summary":"根据市场公开信息及10月21日披露的机构调研信息,知名私募翼虎投资近期对2家上市公司进行了调研,相关名单如下:1)华邦健康 调研纪要:公司坚持医药、医疗大健康发展战略,业务涵盖医药、农化、新材料、旅游五大领域,控股三家上市公司。公司持有普瑞金13.2%股权,为其第三大股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025102200005974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004","BK0229","BK0174","BK0114","603309","BK0042","BK0146","BK0251","BK0188"],"gpt_icon":0},{"id":"2577389165","title":"【私募调研记录】名禹资产调研维力医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2577389165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577389165?lang=zh_cn&edition=full","pubTime":"2025-10-22 08:01","pubTimestamp":1761091265,"startTime":"0","endTime":"0","summary":"根据市场公开信息及10月21日披露的机构调研信息,知名私募名禹资产近期对1家上市公司进行了调研,相关名单如下:1)维力医疗 调研纪要:印尼工厂正处建设及认证阶段,预计2026年Q1末逐步出货,一期主供美国客户,生产导尿管和吸引连接管,后续或扩产喉罩、气管插管等麻醉类产品。当前高毛利产品营收占比已超20%,近年持续提升。在研产品以高附加值为主,新产品上市将优化产品与业务结构,高毛利产品占比有望持续提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025102200005961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603309","BK0251"],"gpt_icon":0},{"id":"2577388734","title":"维力医疗(603309)2025年三季报简析:营收净利润同比双双增长,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2577388734","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577388734?lang=zh_cn&edition=full","pubTime":"2025-10-22 06:02","pubTimestamp":1761084167,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期维力医疗发布2025年三季报。截至本报告期末,公司营业总收入11.91亿元,同比上升12.33%,归母净利润1.92亿元,同比上升14.94%。本报告期维力医疗公司应收账款体量较大,当期应收账款占最新年报归母净利润比达110.95%。目前,公司印尼工厂正处于建设及产品前期认证阶段,预计将在 2026 年第一季度末开始逐步出货。预计转海外生产不会对产品毛利率产生较大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200004454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603309"],"gpt_icon":0},{"id":"2577806711","title":"股市必读:维力医疗(603309)10月21日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2577806711","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577806711?lang=zh_cn&edition=full","pubTime":"2025-10-22 02:57","pubTimestamp":1761073028,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘,维力医疗报收于14.31元,上涨6.08%,换手率4.41%,成交量12.86万手,成交额1.83亿元。来自公司公告汇总:维力医疗将于10月31日召开2025年第三季度业绩说明会,投资者可提前提交问题。业绩披露要点维力医疗2025年第三季度报告显示,报告期内公司实现营业收入446,011,096.01元,同比增长16.09%;年初至报告期末累计营业收入1,191,172,720.75元,同比增长12.33%。归属于上市公司股东的净利润为70,565,993.50元,同比增长16.31%;年初至报告期末累计归母净利润191,642,595.23元,同比增长14.94%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200002268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603309"],"gpt_icon":0},{"id":"2576834111","title":"维力医疗(603309)9月30日股东户数1.89万户,较上期增加9.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576834111","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576834111?lang=zh_cn&edition=full","pubTime":"2025-10-20 17:06","pubTimestamp":1760951198,"startTime":"0","endTime":"0","summary":"证券之星消息,近日维力医疗披露,截至2025年9月30日公司股东户数为1.89万户,较6月30日增加1605.0户,增幅为9.29%。在医疗器械行业个股中,维力医疗股东户数低于行业平均水平,截至9月30日,医疗器械行业平均股东户数为2.15万户。从股价来看,2025年6月30日至2025年9月30日,维力医疗区间涨幅为7.31%,在此期间股东户数增加1605.0户,增幅为9.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000021130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603309","BK0251"],"gpt_icon":0},{"id":"2576831488","title":"维力医疗(603309.SH)发布前三季度业绩,归母净利润1.92亿元,同比增长14.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576831488","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576831488?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:46","pubTimestamp":1760949969,"startTime":"0","endTime":"0","summary":"智通财经APP讯,维力医疗(603309.SH)披露2025年第三季度报告,公司前三季度实现营收11.91亿元,同比增长12.33%;归属于上市公司股东的净利润1.92亿元,同比增长14.94%;扣非净利润1.84亿元,同比增长15.22%;基本每股收益0.65元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357068.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维力医疗(603309.SH)发布前三季度业绩,归母净利润1.92亿元,同比增长14.94%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603309"],"gpt_icon":0},{"id":"2576044675","title":"每周股票复盘:维力医疗(603309)股东质押1460万股并回购99.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2576044675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576044675?lang=zh_cn&edition=full","pubTime":"2025-10-19 05:10","pubTimestamp":1760821818,"startTime":"0","endTime":"0","summary":"来自公司公告汇总:因业绩考核未达标,维力医疗将回购注销996,600股限制性股票,总股本将减少至291,871,418股。公司公告汇总维力医疗股东广州松维企业管理咨询有限公司持有公司股份39,064,856股,占总股本13.34%。本次解除质押后,广州松维持有被质押股份14,600,000股,占其所持股份37.37%,占公司总股本4.99%。截至公告日,其累计质押股份14,600,000股,无限售或冻结情况。本次回购注销已于2025年10月22日完成,公司总股本由292,868,018股减至291,871,418股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900001135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603309"],"gpt_icon":0},{"id":"2575471808","title":"维力医疗(603309)披露股东部分股份质押及解除质押公告,10月13日股价下跌1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575471808","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575471808?lang=zh_cn&edition=full","pubTime":"2025-10-13 17:20","pubTimestamp":1760347232,"startTime":"0","endTime":"0","summary":"截至2025年10月13日收盘,维力医疗报收于13.34元,较前一交易日下跌1.62%,最新总市值为39.07亿元。此外,广州松维近日将此前质押给招商证券的19,350,000股无限售流通股办理了解除质押手续,解除质押日期为2025年10月10日,占其所持股份比例49.53%,占公司总股本比例6.61%。本次解除质押后,广州松维持有的剩余被质押股份数量为14,600,000股,占其所持股份比例37.37%,占公司总股本比例4.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300019987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603309","BK0251"],"gpt_icon":0},{"id":"2570006106","title":"维力医疗(603309.SH)子公司海南维力收到一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2570006106","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570006106?lang=zh_cn&edition=full","pubTime":"2025-09-25 16:12","pubTimestamp":1758787924,"startTime":"0","endTime":"0","summary":"智通财经APP讯,维力医疗(603309.SH)公告,公司全资子公司海南维力医疗科技开发有限公司(简称“海南维力”)于近日收到海南省药品监督管理局颁发的《医疗器械注册证》,产品名称为:一次性使用无菌双腔型喉罩气道导管。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","09996","BK0251","BK1574","159883","BK1222","BK1583","603309","BK1100"],"gpt_icon":0},{"id":"2566922368","title":"维力医疗(603309.SH)子公司产品获得二类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2566922368","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566922368?lang=zh_cn&edition=full","pubTime":"2025-09-12 16:51","pubTimestamp":1757667115,"startTime":"0","endTime":"0","summary":"智通财经APP讯,维力医疗(603309.SH)发布公告,公司全资子公司海南维力医疗科技开发有限公司(简称“海南维力”)于近日收到海南省药品监督管理局颁发的《中华人民共和国医疗器械注册证》,产品名称:一次性使用无菌测温型硅胶导尿管。此次子公司海南维力取得上述医疗器械注册证,有利于丰富子公司产品种类,有助于提高公司产品的市场竞争力,对公司经营将产生积极影响。截至目前,海南维力上述产品尚未进行销售,上述医疗器械注册证的取得,短期内对海南维力及公司的经营业绩影响较小。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1344627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","09997","159883","BK0251","BK1100","BK1574","BK1222","603309","09996"],"gpt_icon":0},{"id":"2564321309","title":"维力医疗(603309.SH)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2564321309","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564321309?lang=zh_cn&edition=full","pubTime":"2025-09-04 15:36","pubTimestamp":1756971409,"startTime":"0","endTime":"0","summary":"智通财经APP讯,维力医疗(603309.SH)公告,公司控股子公司苏州麦德迅医疗科技有限公司(简称“苏州麦德迅”)于近日收到江苏省药品监督管理局颁发的《医疗器械注册证》,产品名称为:图像处理器。该产品临床上与公司及公司控股子公司可视产品配套使用,用于在人体体腔诊断治疗、手术中有效显示摄像头所观察视场区域的影像。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1341440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1574","603309","BK1222","09997","09996","159883","BK1583","BK0251"],"gpt_icon":0},{"id":"2560792649","title":"每周股票复盘:维力医疗(603309)参与设立15,000万元产业投资基金完成备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2560792649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560792649?lang=zh_cn&edition=full","pubTime":"2025-08-17 06:43","pubTimestamp":1755384191,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘,维力医疗报收于14.82元,较上周的14.49元上涨2.28%。本周,维力医疗8月12日盘中最高价报15.44元,股价触及近一年最高点。维智医航已于2025年8月7日完成私募投资基金备案登记手续,备案编码为SBCS25。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700001371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603309","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765921744344,"stockEarnings":[{"period":"1week","weight":-0.0295},{"period":"1month","weight":-0.0866},{"period":"3month","weight":-0.0822},{"period":"6month","weight":0.0893},{"period":"1year","weight":0.0741},{"period":"ytd","weight":0.1467}],"compareEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.0415},{"period":"3month","weight":-0.0133},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.1411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州维力医疗器械股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"18890人(较上一季度增加9.29%)","perCapita":"15451股","listingDate":"2015-03-02","address":"广东省广州市番禺区化龙镇金湖工业城C区4号","registeredCapital":"29187万元","survey":" 广州维力医疗器械股份有限公司的主营业务是麻醉、泌尿、呼吸、血液透析等领域医用导管的研发、生产和销售。公司的主要产品是气管插管、喉罩、支气管插管、可视支气管插管、气管切开插管、麻醉面罩、人工鼻、麻醉呼吸管路、电子镇痛泵、导尿管、导尿包、抗菌导尿管、测温导尿管、引流袋、男用导尿套、精密尿袋清石鞘、微创扩张引流套件、导丝、球囊扩张导管、输尿管扩张器、输尿管导引鞘、取石篮、输尿管支架、输尿管导管。","listedPrice":15.4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"维力医疗(603309)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供维力医疗(603309)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"维力医疗,603309,维力医疗股票,维力医疗股票老虎,维力医疗股票老虎国际,维力医疗行情,维力医疗股票行情,维力医疗股价,维力医疗股市,维力医疗股票价格,维力医疗股票交易,维力医疗股票购买,维力医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"维力医疗(603309)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供维力医疗(603309)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}